News|Articles|March 15, 2020
- Pharmaceutical Technology-03-15-2020
- Volume 2020 eBook
- Issue 1
ALCOA+ and Data Integrity
Author(s)Susan J. Schniepp
Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues.
Advertisement
Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook, March 2020
March 2020
Pages: 10–13
Citation
When referring to this article, please cite it as S. J. Schniepp, “ALCOA+ and Data Integrity," Pharmaceutical Technology Regulatory Sourcebook eBook (March 2020).
Articles in this issue
almost 6 years ago
Resources, Guidelines, and Guidance Documentsalmost 6 years ago
Regulatory and Standard Setting Organizationsalmost 6 years ago
A ‘New Normal’ for Quality?almost 6 years ago
Monograph Development: Why and When to Participate (eBook)almost 6 years ago
A Practical Approach to Pharmacopoeia Compliance (eBook)almost 6 years ago
Inside FDA’s New Gene and Cell Therapy GuidancesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
5
